Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

Beta-blockers for heart failure: why you should use them more.

Ong HT, Kow FP.

J Fam Pract. 2011 Aug;60(8):472-7. No abstract available.

PMID:
21814642
[PubMed - indexed for MEDLINE]
2.

Which beta-blocker for heart failure?

Patel MR, Gattis W.

Am Heart J. 2004 Feb;147(2):238. No abstract available.

PMID:
14760319
[PubMed - indexed for MEDLINE]
3.

In heart failure, all beta-blockers are not necessarily equal.

Tang WH, Militello M, Francis GS.

Cleve Clin J Med. 2003 Dec;70(12):1081-7.

PMID:
14686687
[PubMed - indexed for MEDLINE]
Free Article
4.

[Beta blockers for therapy of chronic heart failure].

Murakami T.

Nihon Naika Gakkai Zasshi. 2005 Feb 10;94(2):248-54. Review. Japanese. No abstract available.

PMID:
15768588
[PubMed - indexed for MEDLINE]
5.

Switching to once-daily evidence-based [beta]-blockers in patients with systolic heart failure or left ventricular dysfunction after myocardial infarction.

Albert NM.

Crit Care Nurse. 2007 Dec;27(6):62-72. Review. No abstract available.

PMID:
18032686
[PubMed - indexed for MEDLINE]
6.

Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.

Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS.

J Am Coll Cardiol. 2010 Apr 27;55(17):1780-7. doi: 10.1016/j.jacc.2010.01.024.

PMID:
20413026
[PubMed - indexed for MEDLINE]
Free Article
7.

Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.

McMurray J, Cohen-Solal A, Dietz R, Eichhorn E, Erhardt L, Hobbs FD, Krum H, Maggioni A, McKelvie RS, Piña IL, Soler-Soler J, Swedberg K.

Eur J Heart Fail. 2005 Aug;7(5):710-21.

PMID:
16087129
[PubMed - indexed for MEDLINE]
8.

The large-scale placebo-controlled beta-blocker studies in systolic heart failure revisited: results from CIBIS-II, COPERNICUS and SENIORS-SHF compared with stratified subsets from MERIT-HF.

Wikstrand J, Wedel H, Castagno D, McMurray JJ.

J Intern Med. 2014 Feb;275(2):134-43. doi: 10.1111/joim.12141. Epub 2013 Oct 24.

PMID:
24118421
[PubMed - indexed for MEDLINE]
9.

Do pharmacological differences among beta-blockers affect their clinical efficacy in heart failure?

Di Lenarda A, Sabbadini G, Sinagra G.

Cardiovasc Drugs Ther. 2004 Mar;18(2):91-3. No abstract available.

PMID:
15293370
[PubMed - indexed for MEDLINE]
10.

The impact of beta-blockade on mortality rates in patients with congestive heart failure.

Goldstein S, Gottlieb SS.

J Card Fail. 2000 Jun;6(2 Suppl 1):15-24. Review.

PMID:
10908094
[PubMed - indexed for MEDLINE]
11.

Beta-adrenoceptor blockers in heart failure.

Song J, White CM.

Conn Med. 1999 Dec;63(12):719-22. Review. No abstract available.

PMID:
10659472
[PubMed - indexed for MEDLINE]
12.

[For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer].

[No authors listed]

MMW Fortschr Med. 2003 Jul 10;145(27-28):60. German. No abstract available.

PMID:
14587195
[PubMed - indexed for MEDLINE]
13.

Beta blockers and congestive heart failure.

Movahed A.

Am Fam Physician. 2000 Dec 1;62(11):2402-4. Review. No abstract available.

PMID:
11130228
[PubMed - indexed for MEDLINE]
Free Article
14.

[Beta blockers: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].

Kawano S.

Nihon Rinsho. 2007 May 28;65 Suppl 5:91-7. Review. Japanese. No abstract available.

PMID:
17571371
[PubMed - indexed for MEDLINE]
15.

[Use of beta-blockers in heart failure].

Inoko M, Nohara R.

Nihon Rinsho. 2003 May;61(5):816-20. Review. Japanese.

PMID:
12755008
[PubMed - indexed for MEDLINE]
16.

Beta-blockers for heart failure.

[No authors listed]

Med Lett Drugs Ther. 2000 Jun 26;42(1081):54-5. No abstract available.

PMID:
10872031
[PubMed - indexed for MEDLINE]
17.

Beta-blockers to reduce mortality in patients with systolic dysfunction: a meta-analysis.

Lee S, Spencer A.

J Fam Pract. 2001 Jun;50(6):499-504.

PMID:
11401736
[PubMed - indexed for MEDLINE]
18.

COMET: a proposed mechanism of action to explain the results and concerns about dose.

Hjalmarson A, Waagstein F.

Lancet. 2003 Sep 27;362(9389):1077; author reply 1077-8. No abstract available.

PMID:
14522544
[PubMed - indexed for MEDLINE]
19.

Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control.

Wai B, Kearney LG, Hare DL, Ord M, Burrell LM, Srivastava PM.

Cardiovasc Diabetol. 2012 Feb 14;11:14. doi: 10.1186/1475-2840-11-14.

PMID:
22330091
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

[Economic analysis of the treatment of heart failure with beta-blockers].

Díez-Manglano J.

Med Clin (Barc). 2013 Sep 21;141(6):265-70. doi: 10.1016/j.medcli.2013.02.011. Epub 2013 Apr 16. Spanish. No abstract available.

PMID:
23597957
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk